AndrewJohnWilsonMD

PubMed

• Discovery of Furanone-Based Radiopharmaceuticals for Diagnostic Targeting of COX-1 in Ovarian Cancer.
  Uddin, M. J.,Wilson, A. J.,Crews, B. C.,Malerba, P.,Uddin, M. I.,Kingsley, P. J.,Ghebreselasie, K.,Daniel, C. K.,Nickels, M. L.,Tantawy, M. N.,Jashim, E.,Manning, H. C...> ;ACS Omega. 2019 Jun 07
• Obesity-Induced Peritoneal Dissemination of Ovarian Cancer and Dominant Recruitment of Macrophages in Ascites.
  Ignacio, RMC.,Lee, E. S.,Wilson, A. J.,Beeghly-Fadiel, A.,Whalen, M. M.,Son, D. S.> ;Immune Netw. 2019 Jan 09
• HASH(0x2fbb110)
  Ignacio, RMC.,Lee, E. S.,Wilson, A. J.,Beeghly-Fadiel, A.,Whalen, M. M.,Son, D. S.> ;Immune Netw. 2018 Sep 06
• HASH(0x2b0e910)
  Collignon, E.,Canale, A.,Al Wardi, C.,Bizet, M.,Calonne, E.,Dedeurwaerder, S.,Garaud, S.,Naveaux, C.,Barham, W.,Wilson, A.,Bouchat, S.,Hubert, P.,Van Lint, C.,Yull, F....> ;Sci Adv. 2018 Jun 26
• 18 citations
  Differential cyclooxygenase expression levels and survival associations in type I and type II ovarian tumors.
  Alicia Beeghly-Fadiel, Andrew J. Wilson, Spencer Keene, Meral El Ramahi, Shu Xu, Lawrence J. Marnett, Oluwole Fadare, Marta A. Crispens, Dineo Khabele> ;Journal of Ovarian Research. 2018 Feb 27
• CXCR2 is a negative regulator of p21 in p53-dependent and independent manner via Akt-mediated Mdm2 in ovarian cancer.
  Ignacio, RMC.,Dong, Y. L.,Kabir, S. M.,Choi, H.,Lee, E. S.,Wilson, A. J.,Beeghly-Fadiel, A.,Whalen, M. M.,Son, D. S.> ;Oncotarget. 2018 Mar 09
• BET Bromodomain Inhibition Synergizes with PARP Inhibitor in Epithelial Ovarian Cancer.
  Karakashev, S.,Zhu, H.,Yokoyama, Y.,Zhao, B.,Fatkhutdinov, N.,Kossenkov, A. V.,Wilson, A. J.,Simpkins, F.,Speicher, D.,Khabele, D.,Bitler, B. G.,Zhang, R.> ;Cell Rep. 2017 Dec 21
• Small molecule inhibitor of the bone morphogenetic protein pathway DMH1 reduces ovarian cancer cell growth.
  Hover, L. D.,Young, C. D.,Bhola, N. E.,Wilson, A. J.,Khabele, D.,Hong, C. C.,Moses, H. L.,Owens, P.> ;Cancer Lett.. 2015 Aug 04
• 84 citations
  Suberoylanilide hydroxamic acid (SAHA) enhances olaparib activity by targeting homologous recombination DNA repair in ovarian cancer
  Panagiotis A. Konstantinopoulos, Andrew J. Wilson, Jeanette Saskowski, Erica Wass, Dineo Khabele> ;Gynecologic Oncology. 2014 Jun 1
• 30 citations
  TR3 Modulates Platinum Resistance in Ovarian Cancer
  Andrew J. Wilson, Annie Y Liu, Joseph T. Roland, Oluwafunmilayo B Adebayo, Sarah Fletcher, James C. Slaughter, Jeanette Saskowski, Marta A. Crispens, Howard W. Jones, ...> ;Cancer Research. 2013 Aug 1
• An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules.
  Basu, A.,Bodycombe, N. E.,Cheah, J. H.,Price, E. V.,Liu, K.,Schaefer, G. I.,Ebright, R. Y.,Stewart, M. L.,Ito, D.,Wang, S.,Bracha, A. L.,Liefeld, T.,Wawer, M.,Gilbert,...> ;Cell. 2013 Aug 29
• 31 citations
  Romidepsin (FK228) combined with cisplatin stimulates DNA damage-induced cell death in ovarian cancer
  Andrew J. Wilson, Anum S. Lalani, Erika Wass, Jeanette Saskowski, Dineo Khabele> ;Gynecologic Oncology. 2012 Dec 1
• 12 citations
  An orthotopic model of platinum-sensitive high grade serous fallopian tube carcinoma.
  Dineo Khabele, Oluwole Fadare, Annie Y Liu, Andrew J. Wilson, Erika Wass, Kevin G. Osteen, Marta A. Crispens> ;International Journal of Clinical and Experimental Pathology. 2012 Jan 1
• The DNA damage mark pH2AX differentiates the cytotoxic effects of small molecule HDAC inhibitors in ovarian cancer cells.
  Wilson, A.J., Holson, E., Wagner, F., Zhang, Y., Fass, D.M., Haggarty, S.J., Bhaskara, S., Hiebert, S.W., Schreiber, S.L., Khabele, D.> ;Cancer Biol Ther. 2011 Sep 15
• Intestinal epithelial-specific PTEN inactivation results in tumor formation.
  Byun, D., Ahmed, N., Nasser, S., Shin, J., Al-Obaidi, S., Goel, S., Corner, G.A., Wilson, A.J., Flanagan, D.J., Williams, D.S., Augenlicht, L.H., Vincan, E., Mariadaso...> ;Am J Physiol Gastrointest Liver Physiol. 2011 Nov
• Helix-mediated protein-protein interactions as targets for intervention using foldamers.
  > ;Amino Acids. 2011 Aug
• Substituent control over dimerization affinity of triply hydrogen bonded heterodimers.
  Gooch, A., McGhee, A.M., Pellizzaro, M.L., Lindsay, C.I., Wilson, A.J.> ;Org Lett. 2011 Jan 21
• Hdac3 is essential for the maintenance of chromatin structure and genome stability.
  Bhaskara, S., Knutson, S.K., Jiang, G., Chandrasekharan, M.B., Wilson, A.J., Zheng, S., Yenamandra, A., Locke, K., Yuan, J., Bonine-Summers, A.R., Wells, C.E., Kaiser,...> ;Cancer Cell. 2010 Nov 16
• The effects of the histone deacetylase inhibitor romidepsin (FK228) are enhanced by aspirin (ASA) in COX-1 positive ovarian cancer cells through augmentation of p21.
  Son, D., Wilson, A.J., Parl, A.K., Khabele, D.> ;Cancer Biol Ther. 2010 Jun 1
• Aprataxin tumor levels predict response of colorectal cancer patients to irinotecan-based treatment.
  Dopeso, H., Mateo-Lozano, S., Elez, E., Landolfi, S., Ramos Pascual, F. J., Hernández-Losa, J., Mazzolini, R., Rodrigues, P., Bazzocco, S., Carreras, M. J., Espín, E.,...> ;Clin Cancer Res. 2010 Apr 15
• Mechanisms of disease pathogenesis in long QT syndrome type 5.
  Harmer, S.C., Wilson, A.J., Aldridge, R., Tinker, A.> ;Am J Physiol Cell Physiol. 2010-02-01
• Apoptotic sensitivity of colon cancer cells to histone deacetylase inhibitors is mediated by an Sp1/Sp3-activated transcriptional program involving immediate-early gen...
  Wilson, A. J., Chueh, A. C., Tögel, L., Corner, G. A., Ahmed, N., Goel, S., Byun, D. S., Nasser, S., Houston, M. A., Jhawer, M., Smartt, H. J., Murray, L. B., Nicholas...> ;Cancer Res. 2010 Jan 15
• The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis.
  Dopeso, H., Mateo-Lozano, S., Mazzolini, R., Rodrigues, P., Lagares-Tena, L., Ceron, J., Romero, J., Esteves, M., Landolfi, S., Hernández-Losa, J., Castaño, J., Wilson...> ;Cancer Res. 2009-09-15
• HDAC4 promotes growth of colon cancer cells via repression of p21.
  Wilson, A.J., Byun, D., Nasser, S., Murray, L.B., Ayyanar, K., Arango, D., Figueroa, M., Melnick, A., Kao, G.D., Augenlicht, L.H., Mariadason, J.M.> ;Mol Biol Cell. 2008 Oct
• PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab.
  Jhawer, M., Goel, S., Wilson, A.J., Montagna, C., Ling, Y., Byun, D., Nasser, S., Arango, D., Shin, J., Klampfer, L., Augenlicht, L.H., Perez-Soler, R., Soler, R.P., M...> ;Cancer Res. 2008 Mar 15
• Join now to see all